SynthesisFrontiers in oncology2020

A 2/1 Sunitinib Dosing Schedule Provides Superior Antitumor Effectiveness and Less Toxicity Than a 4/2 Schedule for Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.

Huan Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.